Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Communist China’s TikTok Blacklists Cuban Anti-Communist Video

Social media users are calling out TikTok, saying the Chinese-owned…
Read more

French Citizens Riot in Response to Plan to Mandate Vaccine Passports

French citizens rioted in response to plans by President Macron…
Read more

Wikipedia Admins Support Banning Editors for Not Using ‘Preferred Pronouns’

A long-time Wikipedia editor for over a decade, Guy Macon,…
Read more